Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)

NCT06127225 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease (NAFLD)

Interventions

DRUG: Proliverenol
DRUG: Placebo caplets of Proliverenol

Sponsor

Dexa Medica Group

Collaborators

[object Object]